NL-OMON33869已完成2 期
A randomised placebo-controlled trial of fixed-dose combination medication in people at raised risk of cardiovascular disease - PILL pilot
niversitair Medisch Centrum Utrecht0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 105
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adults (> 18 years) with a cardiovascular disease (CVD) risk over 5 years of at least 7.5%, determined by the Framingham risk function (Anderson, 1991) using data on age, gender, blood pressure, total cholesterol, HDL cholesterol, diabetes status and cigarette smoking status.
排除标准
- •Clear indication for antiplatelet, blood pressure lowering or cholesterol lowering medications. This includes: current treatment with blood pressure or cholesterol lowering medicines, diabetes mellitus, existing CVD, or individuals with LDL cholesterol, systolic blood pressure or estimated CVD risk values above those recommended for treatment by local guidelines.
研究者
相似试验
进行中（未招募）
1 期
A randomised placebo-controlled trial of fixed-dose combination medication in those at raised risk of cardiovascular disease - PILL PilotCardiovascular DiseaseEUCTR2007-002466-35-GBImperial Ciollege600
进行中（未招募）
1 期
A randomised placebo-controlled trial of fixed-dose combination medication in those at raised risk of cardiovascular disease - PILL PilotMedDRA version: 9.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedCardiovascular DiseaseEUCTR2007-002466-35-NLImperial Ciollege378
进行中（未招募）
1 期
Rifaximin in the prevention of Clostridium Difficile diarrhoea recurrence.C.Difficile antibiotic-associated diarrhoeal infectionEUCTR2012-003205-10-GBniversity of Nottingham151
已完成
3 期
A randomised controlled trial of the efficacy of a carrageenan nasal spray when taken during a cold in reducing asthma exacerbations as measured by the asthma control questionnaire.Asthma exacerbation during a coldColdsRespiratory - AsthmaInfection - Studies of infection and infectious agentsACTRN12615001166561Julian Crane361
进行中（未招募）
1 期
A confirmatory, placebo-controlled, randomised, double-blind, single-dummy, parallel group, ratio-finding study in constipated pain patients to establish an optimal hydromorphone – naloxone ratio with an improved bowel function and a comparable analgesic efficacy compared to hydromorphone alone - Optimisation of Hydromorphone - Naloxone Ratio for the treatment of paiModerate to severe chronic non-cancer or cancer pain with opioid induced constipationMedDRA version: 9.1Level: LLTClassification code 10033371Term: PainMedDRA version: 9.1Level: LLTClassification code 10010774Term: ConstipationEUCTR2008-005315-18-ROMundipharma Research GmbH & Co. KG458